| Date Filed | Type | Description |
| 07/01/2022 |
4
| Ridloff Elena (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $20.29, valued at
$182.6k
|
|
| 06/29/2022 |
4
| Ridloff Elena (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 34,000 options to buy
@ $3.53, valued at
$120k
|
|
| 04/15/2022 |
4/A
| Ridloff Elena (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 10,459 options to buy
@ $49.1, valued at
$513.5k
|
|
| 04/15/2022 |
4/A
| Ridloff Elena (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 20,919 options to buy
@ $56.1, valued at
$1.2M
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/25/2021 |
4
| Ridloff Elena (EVP and CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 36,231 options to buy
@ $49.74, valued at
$1.8M
Granted 9,839 restricted stock units
@ $0 |
|
| 02/08/2021 |
4
| Ridloff Elena (EVP and CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 6,490 shares
@ $0
Sold 2,051 shares
@ $50.61, valued at
$103.8k
|
|
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| Ridloff Elena (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Bought 2,630 shares
@ $19, valued at
$50k
|
|
| 10/08/2020 |
3
| Ridloff Elena (Director) has filed a Form 3 on Kronos Bio, Inc. |
| 05/01/2020 |
4
| Ridloff Elena (EVP and CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $50.7353, valued at
$507.4k
Sold 1,050 shares
@ $49.22, valued at
$51.7k
Exercised 10,000 options to buy
@ $25.12, valued at
$251.2k
Exercised 3,245 restricted stock units
@ $0 |
|
| 01/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2019 |
4
| Ridloff Elena (EVP and CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 11,020 shares
@ $50.595, valued at
$557.6k
Sold 5,502 shares
@ $49.808, valued at
$274k
Sold 19,478 shares
@ $49.094, valued at
$956.3k
Exercised 36,000 options to buy
@ $15.81, valued at
$569.2k
|
|
| 05/01/2019 |
4
| Ridloff Elena (EVP and CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 45,547 options to buy
@ $25.12, valued at
$1.1M
Granted 12,981 restricted stock units
@ $0 |
|
| 04/02/2019 |
4
| Ridloff Elena (EVP and CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 40,000 restricted stock units
@ $0 |
|
| 04/02/2019 |
3
| Ridloff Elena (EVP and CFO) has filed a Form 3 on ACADIA PHARMACEUTICALS INC |